Adam (Moth) and participants in this thread.
So far, I haven't heard anything from the Ben's Friends Advisory Board to restrict my response here, so I will make a start on Moths invitation to comment on the paper "To MVD or not to MVD? Trigeminal Neuralgia – A cervicogenic model." The paper has been featured in the TN Basics tab above.
As Moth is aware, I am critical of the paper for several reasons. That said, I invite anyone in the thread to consider and comment upon four central issues which I shall try to pose as fairly as I can and with courtesy to all who participate here, including Moth.
(1) What are the central points or conclusions of the paper?
(2) How strong does the medical evidence for these points seem?
(3) What background in training and experience does the author bring to the paper -- thus how authoritative should we regard its conclusions to be?
(4) What can we as readers take away for our own constructive use?
These questions may occupy more space than a single posting permits. If so, I will try to continue the thread if I run out of space.
FIRST: My reading of the paper suggests a few central points:
(a) There is no end-all medical explanation or model for chronic neuropathic facial pain. Classification systems are still provisional. Ultimate mechanisms have not yet been reliably confirmed, and there is still much to learn. [On this point, I believe we agree].
(b) There is some medical evidence for models of trigeminal pain other than microvascular decompression. One of those models may involve damage or compression of "trigeminal nerve roots" in the region of C-1-C2 in the cervical spine. [Moth presents his understanding of this evidence, on which I will comment below].
(c) Currently accepted medical practice does not assess for nerve damage in the cervical region when Trigeminal Neuralgia or facial neuropathy is suspected. Nor is significant current medical research being done to explore that possibility. I believe it may be fair to suggest that Moth feels frustration over these realities. [I would agree that this is the present status quo, and I hope I have appropriately summarized it].
(d) The author believes that many patients are inadequately treated or actively harmed by MVD and that a greater reliance should be placed on the physiotherapy techniques of osteopathic medicine with a de-emphasis of invasive surgical procedures. [On this point, I disagree in principle, and will comment at greater length below. Likewise, especially but not exclusively on this one, Moth, please correct my reading if I over-state or distort your conclusions.]
============
SECOND:
How strong does the medical evidence seem to be for the central points of the paper?
Moth clearly believes that there are grounds for reconsidering the microvascular compression model in Type I TN and perhaps for re-interpreting outcomes data on microvascular decompression procedures, even when they work. I have some difficulty in responding to this position meaningfully. Although I am reasonably well read on the existing medical literature of face pain, I am quite definitely NOT a neuroscientist. I don't have the depth of education and experimental exposure that I believe are needed to assess the credibility and plausibility of the many references that Moth has brought together in the paper. And I don't have six months to devote to an exclusive deep-dive research effort to acquire such a background.
What I do know is that there are standards of science which apply to determining how well a theoretical model actually describes medical reality. There is strong evidence in randomized double-blind trials versus weak evidence in individual case studies. Weakest of all are anecdotes published on web sites that have an economic interest in gaining patient acceptance of their products. All of us have seen that self-interest operating in the Net, though not as a rule on Living With TN.
But the potential for investigator bias must lead us to great care in extracting conclusions from published work, including the article we are discussing here. Medical practitioners cannot generalize from individual case reports, and there are a few such reports among Moth references. Nor should we accept uncritically statements that begin with "we would expect", as applied to a conclusion or proposal of medical research. We need to ask "who would expect, and is there a body of evidence that supports this expectation?" These are questions I have suggested to Moth privately, and I believe they are germane.
It is vital that we understand that there is much we simply do not know -- and which as medical laymen (lay persons? the term isn't exclusively male), we perhaps cannot know without the advice of people more deeply grounded in neuroscience. In the meantime, I believe we have a strong ethical requirement not to fall prey to over-generalization -- even if we see evidence that may take us part of the way toward a different point of view on treatment of chronic face pain than that now regarded as "best practice".
As H.L. Mencken once reminded us, "for every problem there is at least one solution which is simple, plausible... and wrong." My central concern in Moth's article, is that I believe he may have fallen into this trap when he posed his conclusions in the way he did. I do not accept an either/or hypothesis for models of face pain. I don't believe we have to choose between vascular compression or cervical compression as "causes" for chronic facial pain. To me -- and founded on nearly 20 years of reading the medical literature -- both hypotheses are credible proposals and BOTH might apply in different patients. They are not mutually exclusive. But to represent them as so seriously weakens the paper as a proposal for engaging the interest and concern of researchers and research institutions.
I will continue my thoughts on the third and fourth issues I've just identified, in a further posting. It may be tomorrow before I get back to complete this commentary.
Regards,
Red